Ibrutinib Resistance
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations (NCT03513562) | Ohio State University Comprehensive Cancer Center | 2019-03-26 |
Track Ibrutinib Resistance automatically
Every clearance here is in the API, with alerts when new ones post.